Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
224 participants
INTERVENTIONAL
2017-08-17
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personal Decision Support System for Heart Failure Management
NCT05651698
Personal Decision Support System for Heart Failure Management
NCT03497871
Patient-centred Home-based Management of Heart Failure
NCT03655496
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure
NCT03238729
Dissertation Project Title: Effects of a Mindfulness-Based Intervention in Chronic Heart Failure
NCT04871178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PCC can be delivered at distance and make health care more effective above and beyond usual care. Inclusion of the principles of PCC in an eHealth support for patients with chronic heart failure (CHF) and/or chronic obstructive pulmonary disease (COPD) will reduce the need for medical care (primary care and hospital admission) amongst these patients by improving self-management, self-efficacy and collaboration in the process of care.
The aim of this project is to implement and evaluate the PCC approach at distance to patients with CHF and/or COPD and their informal care givers to live better and cope more effectively with the disease burden associated with CHF and/or COPD. In the PCC approach, the aims, capabilities and needs of each patient, will be the starting point. Self-care strategies will be reinforced and empowered.
This study is a randomized, open, parallel group intervention study where patients are eligible when they are hospitalized due to worsening CHF and/or COPD. They will be asked before discharge about participation.
Patients admitted to hospital for worsening CHF and/or COPD will be recruited by the research nurses employed in this project from Emergency or on the ward once their condition has stabilized sufficiently.
Patients will be screened against inclusion and exclusion criteria for eligibility to participate in the study. Written informed consent will be obtained. Patients will be randomized into either the control or the intervention arm 1:1. The control group will receive usual care. The intervention group will receive usual care plus a PCC nurse-led intervention. Randomization will be done through computer generated lists and stored in sealed envelopes.
Patients listed in Närhälsan with a confirmed diagnosis of CHF and/or COPD will be screened and sent an informing letter about the study from the chief at each centre. Specially trained registered nurses (RNs) will then screen patients against study inclusion and exclusion criteria and by phone contact eligible patients and inform the patient about the aims of the study and ask if they are interested to participate. If the patient wants to participate a consent form is sent to the patient and then returned to the RN. Then the randomization procedure is performed which is based on a computer-generated list and the patient will be informed about the outcome by phone. Patients randomized to the intervention group will need a computer, smart phone or iPad to participate in the study. Patients who want will have the possibility to be provided an iPad for the duration of their participation in the programme.
Two dedicated full-time Registered Nurses (RN) follow the procedures closely. A monitor controls the protocol adherence. All case record forms, questionnaires and referrals will be constructed (for intervention and usual care groups).
Patients listed at a primary care centre in Närhälsan with CHF and/or COPD will be randomized to usual care (control) or PCC (intervention) after informed and written consent. Follow-up questionnaires on general self-efficacy, cardiac self-efficacy, quality of life, anxiety and depression will be sent out to all patients in both groups after 3,6,12 and 24 months after randomization.
Patients randomized to usual care will be managed by regular evidence-based treatment and care as outlined in treatment guidelines and followed as usual at their local primary care centre.
Patients will be called by a dedicated RN who has received special training in PCC communication at distance, the eHealth platform, CHF and COPD for an initial person-centred dialogue by phone. Based on the patient narrative patient´s goals, resources and needs are identified. The patient (sometimes maybe together with relatives) and the RN formulate a person-centred health plan. This plan is part of and will be up-loaded to the eHealth platform which also contains individual notes and information about CHF and COPD. The plan will be the point of departure for the forthcoming dialogue at distance via the eHealth platform that the patient and the RN will have during the study period (6 months).
The eHealth support contains headings that may inspire the patient to make notes on "a good day" respectively "a bad day". The health plan contain three parts; 1. "My goal is to feel or be able to do". 2. "To be able to reach my goal I will." 3."Support I need to reach my goal". In the communication during the study period between the RN and patient, the personal health plan is discussed and any needs of reformulating the goals may be discussed. The overall goal is to help the patient to identify their own capabilities/resources such as a strong will, social relations etc. and formulate goals that help them increase their self-efficacy and to cope with their condition in daily life.
The RN presents the eHealth support for communication (computer, iPad, smart phone) and they agree on how they will be in contact thereafter. The RN invites the patient and activates their account where he/she can login via an individual user name and formulate, comment, evaluate or develop the health plan. Access to the diary will be password protected. Different forms of symptom-ratings and comments can also be made. The RN can see the patient´s account and make comments. The patient can add or delete staff or private persons that have access to the account. The patient can also limit the access to the account. This makes it relatively simple to connect it to the health account (patient record through internet)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Person-centred care at distance
Person-centred care at distance through an eHealth platform, used both by professionals, patients and relatives
Person-centred care at distance
Person-centred care at distance through an eHealth platform
Usual Care
Evidence-based care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Person-centred care at distance
Person-centred care at distance through an eHealth platform
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women listed at a primary care centre in Närhälsan with a history of confirmed diagnosis of COPD and /or CHF
* Must understand written and spoken Swedish
Exclusion Criteria
* No registered address
* Any severe disease with an expected survival \< 12 months
* Cognitive impairment (SPMSQ score \>6)
* Ongoing documented diagnosis of alcohol or drug abuse
* Other disease that can interfere with follow-up (e.g. severe depression, other severe mental illness)
* Patient participating in another conflicting randomized study
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Inger Ekman, Professor
Role: PRINCIPAL_INVESTIGATOR
Institute of health and care sciences, Centre for person-centred care (GPCC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Primary health care
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barenfeld E, Ekman I, Cederberg M, Fors A, Ali L, Gyllensten H. Patient and healthcare professional engagement and time use within a randomised controlled trial: investigating intervention costs associated with remote person-centred care in Sweden. BMJ Open. 2025 Oct 9;15(10):e099034. doi: 10.1136/bmjopen-2025-099034.
Harvey BP, Barenfeld E, Fors A, Ekman I, Swedberg K, Gyllensten H. Economic evaluation of a person-centred care intervention with a digital platform and structured telephone support for people with chronic heart failure and/or chronic obstructive pulmonary disease: results from a randomised controlled trial in Sweden. BMJ Open. 2025 Oct 9;15(10):e093083. doi: 10.1136/bmjopen-2024-093083.
Ali L, Wallstrom S, Fors A, Barenfeld E, Fredholm E, Fu M, Goudarzi M, Gyllensten H, Lindstrom Kjellberg I, Swedberg K, Vanfleteren LEGW, Ekman I. Effects of Person-Centered Care Using a Digital Platform and Structured Telephone Support for People With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure: Randomized Controlled Trial. J Med Internet Res. 2021 Dec 13;23(12):e26794. doi: 10.2196/26794.
Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.
Ali L, Wallstrom S, Barenfeld E, Fors A, Fredholm E, Gyllensten H, Swedberg K, Ekman I. Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial. BMJ Open. 2020 Jul 19;10(7):e036356. doi: 10.1136/bmjopen-2019-036356.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROTECT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.